支气管动脉灌注化疗治疗非小细胞肺癌的疗效观察

Clinical observation on treatment of bronchial artery infusion chemotherapy for non-small cell lung cancer

目的探讨支气管动脉灌注治疗非小细胞肺癌(NSCLC)的疗效。方法按数字随机法将60例NSCLC患者分为观察组和对照组,每组30例。对照组患者给予全身静脉化疗,观察组患者给予支气管动脉化疗。比较两组患者的近期疗效、不良反应及并发症发生情况。结果观察组患者治疗效果显著优于对照组患者,差异有统计学意义(P<0.05);观察组患者的不良反应和并发症显著少于对照组,差异有统计学意义(P<0.05)。结论支气管动脉灌注化疗治疗非小细胞肺癌,疗效显著,不良反应少,操作简便,对患者损伤较小,易被患者接受,值得临床推广应用。

Objective To explore the bronchial artery after interventional treatment of lung cancer clinical curative effect observation and prognosis analysis.Methods From 2010 to 2014 treated 60 cases of bronchial lung cancer patients,randomly divided into observation group and control group,30 cases in each group as research object.The control group was treated by systemic intravenous therapy,observation group take intervention treatment,two groups of treatment effect observed.Results The observation of two groups of patients with solid tumor treatment,the results found that observation group the treatment effect was significantly better than the control group,difference was statistically significant（P 〈 0.05）;to observe adverse reactions and complications of the two groups of patients,the results found that the observation group of patients with adverse reaction and complications were significantly less than the control group,the difference was statistically significant（P 〈 0.05）.Conclusion The treatment of bronchial artery interventional lung cancer type,simple operation,less damage to patients,easily accepted by patients,help patients,promote patients recover at an early date.